Long-term outcomes in adults born preterm with symptomatic patent ductus arteriosus
OBJECTIVE: To compare outcomes in young adults born prematurely with and without symptomatic patent ductus arteriosus (PDA) during infancy. STUDY DESIGN: Young adults born preterm (≤32 weeks gestation; n = 107) were recruited from the Parkland Health Neonatal Intensive Care Unit (NICU) Registry and compared based on presence of symptomatic PDA during their NICU stay (n = 23 with PDA), defined as clinical evidence of large left-to-right shunt or congestive heart failure. RESULTS: Systolic blood pressure was similar, but the PDA group exhibited higher resting diastolic blood pressure (80 ± 10 versus 74 ± 12 mmHg, p = 0.02). Biventricular systolic function was similar. However, tissue Doppler imaging (TDI) velocities at the lateral/septal aspect of the mitral annulus were lower and RV end-diastolic diameter larger in the PDA group. CONCLUSIONS: Individuals born preterm with a symptomatic PDA exhibited elevated diastolic blood pressure, slightly lower diastolic function, and larger right ventricular size in early adulthood.
Authors
- Gregory P. Barton (ORCID: https://orcid.org/0000-0001-7471-5488)
- Alysha Joseph (ORCID: https://orcid.org/0000-0003-2422-5813)
- Kara N. Goss (ORCID: https://orcid.org/0000-0003-2015-9169)
- Alvin Chandra (ORCID: https://orcid.org/0000-0003-1753-1644)
- JARETT BERRY
- Nataly J. Sanchez‐Solano (ORCID: https://orcid.org/0000-0002-4651-6016)
Institutions
- Children's Hospital of Philadelphia (US)
- Southwestern Medical Center (US)
- The University of Texas Southwestern Medical Center (US)
- The University of Texas Health Science Center at Tyler (US)
Publication Details
- Journal
- Journal of Perinatology
- Published
- 2026-04-15
- DOI
- https://doi.org/10.1038/s41372-026-02685-y
- Primary Topic
- Cardiovascular Conditions and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Doris Duke Charitable Foundation
- American Heart Association
- Harry S. Moss Heart Trust
- National Heart, Lung, and Blood Institute
- National Center for Advancing Translational Sciences